ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04650	Natural killer cell mediated cytotoxicity	5/27	97/7206	2.54381063491e-05
ko04660	T cell receptor signaling pathway	5/27	124/7206	8.29341759577e-05
ko04612	Antigen processing and presentation	4/27	77/7206	0.000175524784797
ko05416	Viral myocarditis	3/27	55/7206	0.00108102455584
ko05332	Graft-versus-host disease	2/27	18/7206	0.00199355504126
ko05330	Allograft rejection	2/27	24/7206	0.00354675678615
ko05152	Tuberculosis	4/27	187/7206	0.00482884524448
ko05320	Autoimmune thyroid disease	2/27	29/7206	0.00515752797603
ko04658	Th1 and Th2 cell differentiation	3/27	96/7206	0.00531584939688
ko05340	Primary immunodeficiency	2/27	30/7206	0.00551320375033
ko04940	Type I diabetes mellitus	2/27	32/7206	0.00625742278743
ko04659	Th17 cell differentiation	3/27	106/7206	0.00700131958337
ko05150	Staphylococcus aureus infection	2/27	36/7206	0.00787507655413
ko04666	Fc gamma R-mediated phagocytosis	3/27	122/7206	0.0102971425009
ko05145	Toxoplasmosis	3/27	126/7206	0.0112403674076
ko04514	Cell adhesion molecules (CAMs)	3/27	130/7206	0.012232370184
ko05321	Inflammatory bowel disease (IBD)	2/27	56/7206	0.0183858754329
ko04640	Hematopoietic cell lineage	2/27	64/7206	0.0236317696625
ko05164	Influenza A	3/27	167/7206	0.0237830533658
ko05140	Leishmaniasis	2/27	75/7206	0.03172107234
ko04664	Fc epsilon RI signaling pathway	2/27	77/7206	0.0332947878341
ko05131	Shigellosis	2/27	82/7206	0.0373608770836
ko05133	Pertussis	2/27	87/7206	0.0416090062192
ko05323	Rheumatoid arthritis	2/27	89/7206	0.0433575124729
ko04064	NF-kappa B signaling pathway	2/27	96/7206	0.0496901451412